| Literature DB >> 35547012 |
Swapnil Tripathi1, Shabrin Fhatima1, Dharati Parmar1, Dhirendra Pratap Singh1, SukhDev Mishra2, Rajeev Mishra3, Gyanendra Singh1.
Abstract
Arsenic and chromium are the most common environmental toxicants prevailing in nature. Hence, the present study endeavors to investigate the salutary effects of Coenzyme Q10 (CoQ10), Biochanin A (BCA), and Phloretin (PHL) on the combined neurotoxic impact of arsenic and chromium in the Swiss albino mice (Mus musculus). Sodium meta-arsenite (100 ppm) and potassium dichromate (75 ppm) were given orally in conjugation with CoQ10 (10 mg/kg), BCA & PHL (50 mg/kg each) in accordance with body weight per day for the 2 weeks experimental duration. Weight reduction was figured out in the exposed toxic group of arsenic and chromium in contrast with the comparison group (control), and with the selected anti-oxidants treatment, it rose significantly to the basal status (p < 0.05). The concentration of arsenic and chromium was reduced significantly (p < 0.001) amidst all the natural compounds co-medicated groups. Anti-oxidant indicators, viz. lipid peroxidation (LPO) and protein carbonyl content (PCC), were found elevated, with reduction observed in the levels of superoxide dismutase (SOD), reduced glutathione (GSH), glutathione s-transferase (GST), and total thiols (TT) in the arsenic and chromium, co-exposed mice. The alterations in redox homeostasis were well corroborated with the estimations of cholinesterase's enzymes (p < 0.05) along with DNA fragmentation assay and altered Nrf2 signaling. The administration of CoQ10, BCA, and PHL ameliorated the effects of arsenic and chromium induced oxidative stress in the exposed mice. Our research unfolds the remedial outcome of these natural compounds contrary to the combined arsenic and chromium associated-neurotoxicity in the experimental model. © King Abdulaziz City for Science and Technology 2022.Entities:
Keywords: Antioxidants; Arsenic; Biochanin A; Chromium; Coenzyme Q10; Natural compounds; Nrf2; Oxidative stress; Phloretin
Year: 2022 PMID: 35547012 PMCID: PMC9023648 DOI: 10.1007/s13205-022-03171-w
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.893